Featured Story | By Annalee Armstrong It’s been a tough week for Sesen Bio. The company had been preparing to welcome a drug approval for the bladder cancer drug Vicineum, but instead, the FDA rejected it. Then, a bombshell report from Stat landed, suggesting that the rejection should not have come as a surprise. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor The co-founder of heart regeneration biotech Novo Biosciences engaged in research misconduct by falsifying or fabricating data, according to the Office of Research Integrity (ORI). Viravuth Yin settled the case without admitting or denying the ORI’s findings of research misconduct. read more By Ben Adams Former research staffers often leave after a major buyout deal, and we might just be starting to see that with MyoKardia after its $13.1 billion merger with Bristol Myers Squibb last year as Jeff Douglas moves to Esker Therapeutics. read more Sponsored By: BioIVT Machine-learning-based techniques in drug and diagnostic discovery require copious amounts of biomedical data, and that data needs to be validated to ensure success. read more By Nick Paul Taylor Visus Therapeutics is moving quickly to establish itself in the ophthalmic therapy space. Days after raising $20 million to fuel its pursuit of AbbVie in one indication, Visus has disclosed two deals that add to its R&D options. read more By Kyle LaHucik Thomas Christély will be MetrioPharm's next CEO starting October 1. He joins the Swiss biotech from German virology company MYR Pharmaceuticals, where he was managing director and CFO until Gilead Sciences bought the biotech for €1.15 billion last December. read more By Andrea Park Since making its first foray into the robotic surgery arena half a decade ago, Zimmer Biomet has been slowly but surely building out its line of surgical robot systems to guide surgeons through operations on practically every part of the body. read more By Kyle LaHucik UCSD scientists discovered a protein pathway that they believe could inspire new treatments for Alzheimer's disease. The researchers found that by blocking the toxic actions of amyloid beta in mouse models, they were able to protect synapses, which are critical to preserving memory. read more By Noah Higgins-Dunn Johnson & Johnson is receiving fierce criticism from a group of outspoken shareholders for exporting millions of COVID-19 vaccine doses from a facility in South Africa to Europe despite glaring access inequalities, contributing to a “vaccine apartheid." read more By Robert King The American Hospital Association wants to meet with leaders of federal agencies that are examining the impact of hospital mergers, as the group seeks to push back on scrutiny of such deals. read more Resources Sponsored by: XIFIN inc. Download Frost & Sullivan’s enabling technologies best practices report to learn more about the four core functionalities required in successful precision medicine programs. Sponsored by: XIFIN inc. Download Frost & Sullivan’s enabling technologies best practices report to learn more about the four core functionalities required in successful precision medicine programs. Sponsored by: Patheon by Thermo Fisher Scientific Learn how a decentralized clinical trial strategy improves patient recruitment, reduces drop-out rates, and ultimately streamlines the path to the next trial phase. Sponsored by: Patheon by Thermo Fisher Scientific Learn how to build a robust packaging strategy and the key technical considerations in packaging design and operational planning to enable rapid commercialization of pharmaceuticals. Sponsored by: Patheon by Thermo Fisher Scientific Learn how regulations are changing and key considerations for commercializing cell and gene therapies without sacrificing quality. Sponsored By: LabVantage Solutions, Inc. Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. | 
